Literature DB >> 25513818

Cerebral white matter integrity during primary HIV infection.

Patrick W Wright1, Florin F Vaida, Ricardo J Fernández-de Thomas, Jerrel Rutlin, Richard W Price, Evelyn Lee, Julia Peterson, Dietmar Fuchs, Joshua S Shimony, Kevin R Robertson, Rudolph Walter, Dieter J Meyerhoff, Serena Spudich, Beau M Ances.   

Abstract

OBJECTIVE: Inflammation and infection within the central nervous system is initiated during primary HIV infection (PHI), but the association of these processes with the integrity of brain white matter during PHI is unknown.
DESIGN: We used diffusion tensor imaging (DTI) in this prospective cross-sectional neuroimaging study to determine the extent of white matter involvement in early HIV infection.
METHODS: Antiretroviral-naive PHI (defined as <1 year after infection, n = 62), chronic HIV infection (CHI, n = 16), and HIV-uninfected (n = 19) participants had DTI, laboratory, and neuropsychometric performance assessments. DTI metrics were examined using region of interest and whole brain voxelwise analyses. Linear mixed-effects models assessed correlations between DTI measures and laboratory and neuropsychometric performance values.
RESULTS: PHI participants were assessed at a median 4.1 months after estimated infection, and had median CD4 cell count of 573 cells/μl, and HIV-1 RNA viral load of 4.5 log10 copies/ml in plasma and 2.6 log10 copies/ml in cerebrospinal fluid (CSF). DTI metrics in PHI individuals were similar to HIV- participants and correlated with disruptions in the blood-brain barrier (indicated by CSF/plasma albumin ratio and CSF protein). CHI participants had significant loss of white matter integrity that correlated with biomarkers of infection and inflammation (blood viral load, CD4 T-cell count, and neopterin, and CSF white blood cell). Within the PHI group, DTI metrics inversely correlated with increasing days since infection.
CONCLUSION: In individuals assessed during PHI, group DTI measures suggested relative preservation of white matter microstructural integrity, but were associated with disruption of the blood-brain barrier and estimated duration of infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25513818      PMCID: PMC4916955          DOI: 10.1097/QAD.0000000000000560

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  36 in total

1.  Nonrigid registration using free-form deformations: application to breast MR images.

Authors:  D Rueckert; L I Sonoda; C Hayes; D L Hill; M O Leach; D J Hawkes
Journal:  IEEE Trans Med Imaging       Date:  1999-08       Impact factor: 10.048

2.  Effects of cell volume fraction changes on apparent diffusion in human cells.

Authors:  A W Anderson; J Xie; J Pizzonia; R A Bronen; D D Spencer; J C Gore
Journal:  Magn Reson Imaging       Date:  2000-07       Impact factor: 2.546

Review 3.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

4.  Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies.

Authors:  David F Tate; Mehul Sampat; Jaroslaw Harezlak; Mark Fiecas; Joseph Hogan; Jeffrey Dewey; Daniel McCaffrey; Daniel Branson; Troy Russell; Jared Conley; Michael Taylor; Giovanni Schifitto; Giavoni Schifitto; J Zhong; Eric S Daar; Jeffrey Alger; Mark Brown; Elyse Singer; T Campbell; D McMahon; Y Tso; Janetta Matesan; Scott Letendre; S Paulose; Michelle Gaugh; C Tripoli; Constantine Yiannoutsos; Erin D Bigler; Ronald A Cohen; Charles R G Guttmann; Bradford Navia
Journal:  J Neurovirol       Date:  2011-05-10       Impact factor: 2.643

5.  Diffusion tensor imaging reveals white matter reorganization in early blind humans.

Authors:  J S Shimony; H Burton; A A Epstein; D G McLaren; S W Sun; A Z Snyder
Journal:  Cereb Cortex       Date:  2005-12-28       Impact factor: 5.357

6.  Callosal degradation in HIV-1 infection predicts hierarchical perception: a DTI study.

Authors:  Eva M Müller-Oehring; Tilman Schulte; Margaret J Rosenbloom; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Neuropsychologia       Date:  2009-12-16       Impact factor: 3.139

7.  Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection.

Authors:  Susan J Little; Simon D W Frost; Joseph K Wong; Davey M Smith; Sergei L Kosakovsky Pond; Caroline C Ignacio; Neil T Parkin; Christos J Petropoulos; Douglas D Richman
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

8.  Diffusion alterations in corpus callosum of patients with HIV.

Authors:  Y Wu; P Storey; B A Cohen; L G Epstein; R R Edelman; A B Ragin
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

9.  Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.

Authors:  B M Ances; D Sisti; F Vaida; C L Liang; O Leontiev; J E Perthen; R B Buxton; D Benson; D M Smith; S J Little; D D Richman; D J Moore; R J Ellis
Journal:  Neurology       Date:  2009-09-01       Impact factor: 9.910

10.  Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.

Authors:  Serena S Spudich; Annelie C Nilsson; Nicole D Lollo; Teri J Liegler; Christos J Petropoulos; Steven G Deeks; Ellen E Paxinos; Richard W Price
Journal:  BMC Infect Dis       Date:  2005-11-02       Impact factor: 3.090

View more
  33 in total

Review 1.  CROI 2016: Neurologic Complications of HIV Infection.

Authors:  Serena S Spudich; Beau M Ances
Journal:  Top Antivir Med       Date:  2016 May-Jun

Review 2.  Novel Neuroimaging Methods to Understand How HIV Affects the Brain.

Authors:  Paul M Thompson; Neda Jahanshad
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

Review 3.  Neurocognitive Phenotyping of HIV in the Era of Antiretroviral Therapy.

Authors:  Robert Paul
Journal:  Curr HIV/AIDS Rep       Date:  2019-06       Impact factor: 5.071

Review 4.  Brain PET Imaging: Value for Understanding the Pathophysiology of HIV-associated Neurocognitive Disorder (HAND).

Authors:  Sanhita Sinharay; Dima A Hammoud
Journal:  Curr HIV/AIDS Rep       Date:  2019-02       Impact factor: 5.071

5.  White matter hyperintensities correlate to cognition and fiber tract integrity in older adults with HIV.

Authors:  Christa Watson; Edgar Busovaca; Jessica M Foley; I Elaine Allen; Christopher G Schwarz; Neda Jahanshad; Talia M Nir; Pardis Esmaeili-Firidouni; Benedetta Milanini; Howard Rosen; Owen T Carmichael; Paul M Thompson; Victor G Valcour
Journal:  J Neurovirol       Date:  2017-01-18       Impact factor: 2.643

6.  Identifying the white matter impairments among ART-naïve HIV patients: a multivariate pattern analysis of DTI data.

Authors:  Zhenchao Tang; Zhenyu Liu; Ruili Li; Xin Yang; Xingwei Cui; Shuo Wang; Dongdong Yu; Hongjun Li; Enqing Dong; Jie Tian
Journal:  Eur Radiol       Date:  2017-04-10       Impact factor: 5.315

7.  Reliability of White Matter Microstructural Changes in HIV Infection: Meta-Analysis and Confirmation.

Authors:  E E O'Connor; A Jaillard; F Renard; T A Zeffiro
Journal:  AJNR Am J Neuroradiol       Date:  2017-06-08       Impact factor: 3.825

8.  Increased posterior cingulate cortex efficiency may predict cognitive impairment in asymptomatic HIV patients.

Authors:  Nina Ventura; Linda Douw; Diogo G Correa; Tania M Netto; Rafael F Cabral; Fernanda Cristina Rueda Lopes; Emerson L Gasparetto
Journal:  Neuroradiol J       Date:  2018-06-13

Review 9.  An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?

Authors:  Anantha Ram Nookala; Joy Mitra; Nitish S Chaudhari; Muralidhar L Hegde; Anil Kumar
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

10.  Beneficial Effects of Cannabis on Blood-Brain Barrier Function in Human Immunodeficiency Virus.

Authors:  Ronald J Ellis; Scott Peterson; Mariana Cherner; Erin Morgan; Rachel Schrier; Bin Tang; Martin Hoenigl; Scott Letendre; Jenny Iudicello
Journal:  Clin Infect Dis       Date:  2021-07-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.